iifl-logo

Welcure Drugs & Pharmaceuticals Ltd Share Price

10.64
(3.70%)
May 9, 2025|12:00:00 AM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Equities

Futures

Option

  • Open10.26
  • Day's High10.77
  • 52 Wk High15.81
  • Prev. Close10.26
  • Day's Low10.05
  • 52 Wk Low 4.3
  • Turnover (lac)8.37
  • P/E60.35
  • Face Value10
  • Book Value9.05
  • EPS0.17
  • Mkt. Cap (Cr.)119.71
  • Div. Yield0
View All Historical Data
No Records Found

Welcure Drugs & Pharmaceuticals Ltd KEY RATIOS

Sector

Castings, Forgings & Fastners

Open

10.26

Prev. Close

10.26

Turnover(Lac.)

8.37

Day's High

10.77

Day's Low

10.05

52 Week's High

15.81

52 Week's Low

4.3

Book Value

9.05

Face Value

10

Mkt Cap (₹ Cr.)

119.71

P/E

60.35

EPS

0.17

Divi. Yield

0

Welcure Drugs & Pharmaceuticals Ltd Corporate Action

6 May 2025

12:00 AM

Board Meeting

Agenda : Audited Result

arrow

9 Sep 2024

12:00 AM

AGM

Announcement Date: 09 Sep, 2024

arrow

9 Sep 2024

12:00 AM

BookCloser

arrow

Welcure Drugs & Pharmaceuticals Ltd NEWS AND UPDATE

No Record Found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Welcure Drugs & Pharmaceuticals Ltd SHAREHOLDING SNAPSHOT

09 May, 2025|06:49 PM
  • Foreign Promoter
  • Indian Promoter
  • Institutions
  • Non Institutions
  • Custodies

Promoter- 0.00%

Foreign: 0.00%

Indian: 0.00%

Non-Promoter- 1000.00%

Institutions: 0.00%

Non-Institutions: 100.00%

Custodian: 0.00%

Share Price

Welcure Drugs & Pharmaceuticals Ltd FINANCIALS

Balance Sheet

Profit & Loss

Cash Flow

Ratios

Results

Y/e 31 Mar( In .Cr)Mar-2024Mar-2023Mar-2022Mar-2021

Equity Capital

13.44

13.44

12.12

12.12

Preference Capital

0

0

0

0

Reserves

-12.1

-11.92

-12.03

-12.05

Net Worth

1.34

1.52

0.08

0.06

Minority Interest

View Balance Sheet
Y/e 31 Mar( In .Cr)Mar-2022Mar-2021Mar-2020Mar-2018

Revenue

0.1

0.13

0.08

0.05

yoy growth (%)

-21.23

61.57

65

-44.19

Raw materials

0

0

0

0

As % of sales

0

0

0

0

Employee costs

-0.01

0

0

0

View Profit & Loss
Y/e 31 Mar( In .Cr)Mar-2022Mar-2021Mar-2020Mar-2018

Profit before tax

0.02

0.05

0

-0.01

Depreciation

0

0

0

0

Tax paid

0

0

0

0

Working capital

0.02

0.03

-0.01

-0.02

Other operating items

View Cash Flow
Y/e 31 MarMar-2022Mar-2021Mar-2020Mar-2018

Growth matrix (%)

Revenue growth

-21.23

61.57

65

-44.19

Op profit growth

-57.05

-661.27

-52.28

-174.27

EBIT growth

-57.2

-684.21

-51.13

-169.92

Net profit growth

-57.2

-684.21

-51.13

-169.92

View Ratios

No Record Found

Welcure Drugs & Pharmaceuticals Ltd Peer Comparison

Company Name
LTP
(₹)
P/E
(%)
Mkt.Cap
(₹Cr.)
NP Qtr
(₹Cr.)
Div.Yield
(%)
Sales Qtr
(₹.Cr)
Book Value
(₹)

Bharat Forge Ltd

BHARATFORG

1,114

36.253,259.07345.630.762,163.03219.08

AIA Engineering Ltd

AIAENG

3,119.65

27.9129,424.65206.840.51891.81652.52

PTC Industries Ltd

PTCIL

12,220.5

018,311.358.13058.37871.96

CIE Automotive India Ltd

CIEINDIA

409.85

26.5815,548.17218.541.711,163.45140.56

Ramkrishna Forgings Ltd

RKFORGE

579.6

29.1110,498.9999.550.34952.72160.95

Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.

MORE ABOUT Welcure Drugs & Pharmaceuticals Ltd

Management

Register Office

Registrar Office

Independent Director

Pradeep Dnyaneshwar Terse

Managing Director

Altaf Hussain Shah

Non Executive Director

Deepika Krishnan Iyer

Non Executive Director

Suraj Chagan Solanki

Registered Office


Tel: -

Website: -

Email: -

Registrar Office


Tel: -

Website: -

Email: -

Reports by Welcure Drugs & Pharmaceuticals Ltd

Summary

Incorporated on 4 Jun.92, Welcure Drugs And Pharmaceuticals (WDPL) was promoted by D C Jain, Sanjeev Jain and Sandeep Jain. The promoters have interests in other companies such as Paam Pharmaceuticals, Pioneer Products, Alirox Abrasives, A K Laboratories, etc. WDPL had come out with a Rs 4-cr public issue in Aug.94 to part-finance the Rs 7-cr project to manufacture bulk drugs in Rajasthan and finance investments in a subsidiary, A K Laboratories (AKL). The company has also submitted the letter of offer for a Rs 7.09-cr rights issue of equity shares in Jan.96 to finance its expansion programmes.Products of WDPL include bulk drugs such as ampicillin and trimethoprim, drugs intermediates and pharmaceutical formulations. It has decided to add amoxycillin and cloxacillin to its range with provision to manufacture ibuprofen. It manufactures over a hundred varieties of tablets, capsules and dry syrups, sulpha drugs, vitamins, analgesics, etc. Its subsidiary, AKL, manufactures 6-APA, a key drug intermediate in the manufacture of semi-synthetic penicillin. The company has decided to set up new sections of paediatrics and veterinary drugs and to diversify into ointments and liquid syrups. The new products of the company WELSTAP , X- CLOX , ETHAMBUTOL, RIFA- Z , CETIRIZIN , NORTIN have been well accepted in the market.The Company has entered into a collaboration agreement with a russian company to act as their sole selling agent for a unique medicine Stevioside, an alternate to sugar, S
Read More

Company FAQs

What is the Welcure Drugs & Pharmaceuticals Ltd share price today?

The Welcure Drugs & Pharmaceuticals Ltd shares price on BOMBAY STOCK EXCHANGE (BSE) is ₹10.64 today.

What is the Market Cap of Welcure Drugs & Pharmaceuticals Ltd?

Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Welcure Drugs & Pharmaceuticals Ltd is ₹119.71 Cr. as of 09 May ‘25

What is the PE and PB ratio of Welcure Drugs & Pharmaceuticals Ltd?

The PE and PB ratios of Welcure Drugs & Pharmaceuticals Ltd is 60.35 and 1.13 as of 09 May ‘25

What is the 52 Week High and Low of Welcure Drugs & Pharmaceuticals Ltd?

The 52-week high/low is the highest and lowest price at which a Welcure Drugs & Pharmaceuticals Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Welcure Drugs & Pharmaceuticals Ltd is ₹4.3 and ₹15.81 as of 09 May ‘25

What is the CAGR of Welcure Drugs & Pharmaceuticals Ltd?

Welcure Drugs & Pharmaceuticals Ltd's CAGR for 5 Years at 86.07%, 3 Years at 21.64%, 1 Year at 112.86%, 6 Month at 27.14%, 3 Month at -0.48% and 1 Month at 26.98%.

What is the shareholding pattern of Welcure Drugs & Pharmaceuticals Ltd?

The shareholding pattern of Welcure Drugs & Pharmaceuticals Ltd is as follows:
Promoters - 0.00 %
Institutions - 0.00 %
Public - 100.00 %

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.